• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

covid-19

  1. Why is Pascal feeding the press?

    Pascal Soriot, chief executive of AstraZeneca, told the Sunday Times: "We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else. “I can't tell you more because we will publish at some point." In a complicated scenario where...
  2. Novel Coronavirus (COVID-19) – Pharma Industry’s Action Plan

    Amidst the pandemic, the pharma industries hold a prominent role to play to combat the crisis. They have significantly working on their research and development to figure out the roots of the virus and develop a cure for it. The deepest concern that pertains to the COVID-19 pandemic is...
  3. Success of Vaccines & Antibiotics in Coronavirus (COVID-19) Pandemic

    Experiments, clinical trials and researches are on peak across the world to come up with a vaccine for COVID-19. Administrative bodies have approved certain medicines and antibiotics to treat the virus. However, no vaccine or cure has been found yet. Know the advancements and success of the...
  4. Veru's progress in the COVID-19 cure race

    On Tuesday, Veru received FDA permission to initiate a phase 2 clinical trial to assess the efficacy of VERU-111 in combating COVID-19, the global pandemic disease caused by the novel coronavirus SARS-CoV-2. Veru has initiated the study and expects the first patient to be dosed within 2 weeks...
  5. COVID-19 beneficial for Mylan, A visual treat of earnings

    Mylan N.V. (MYL) reported its financial results for the quarter ended March 31, 2020, on Monday before the market opens. The company reaffirmed its financial guidance for the full-year 2020. The results were driven by overall volume growth, which was favorably impacted by increased customer...
  6. Regeneron advances in COVID-19 virus cure

    Regeneron Pharmaceuticals, Inc. (REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The results exceeded analysts’ expectations. The company is advancing REGN-COV2, a novel investigational antibody “cocktail” treatment designed to prevent and treat the...
  7. COVID -19: Florida to Re-Open Next Week

    Are you willing to go back into your accounts to save your job?
  8. Infographic: Abbott Laboratories (ABT) Q1 2020 earnings

    Abbott Laboratories (ABT) reported its financial results for the quarter ended March 31, 2020 today. The company reported a 16% drop in earnings for the first quarter of 2020 due to tax expense despite a 2.5% increase in the top-line. Abbott is suspending its previously announced annual...
  9. Need Info Roche SARS-CoV-2 Test for COVID-19.

    I'm doing some pro-bono research and consulting on the questions below regarding Roche SARS-CoV-2 Test for COVID-19. I AM NOT consulting or working for Roche! Has a cost or price been established for this test (lab &/or patient)? How many cobas® 6800 and cobas® 8800 Systems are installed in...
  10. Roche SARS-CoV-2 Test for COVID-19

    I'm doing some pro-bono research and consulting on the questions below regarding Roche SARS-CoV-2 Test for COVID-19. I AM NOT consulting or working for Roche! Has a cost or price been established for this test (lab &/or patient)? How many cobas® 6800 and cobas® 8800 Systems are installed in...